All Clarivate websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.

More information on our cookie policy.

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
  • Special reports
    • Artificial intelligence
    • Coronavirus
    • IVDs on the rise
    • Top Biopharma Trends of 2021
    • Top Med-tech Trends of 2021
    • Premium reports
      • BioWorld Financings Reports
      • Disease Incidence & Prevalence Summaries

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, July 3, 2022
Home » Topics » Science

Science
Science RSS Feed RSS

BioWorld MedTech's Diagnostics Extra

Oct. 25, 2019
By Meg Bryant and Anette Breindl
No Comments
Keeping you up to date on recent developments in diagnostics.
Read More
From mold to therapeutic gold?

Promising new analgesics developed from Australian mold

Oct. 24, 2019
By John Fox
No Comments
Australian scientists have discovered promising new candidate analgesic molecules derived from a Penicillium fungus, which represents a promising resource for the development of safer new analgesics, they reported in the Oct. 14, 2019, edition of Proceedings of the National Academy of Sciences (PNAS).
Read More

BioWorld MedTech's Orthopedics Extra

Oct. 24, 2019
By Holland Johnson
No Comments
Keeping you up to date on recent developments in orthopedics.
Read More
From mold to therapeutic gold?

Promising new analgesics developed from Australian mold

Oct. 24, 2019
By John Fox
No Comments
Australian scientists have discovered promising new candidate analgesic molecules derived from a Penicillium fungus, which represents a promising resource for the development of safer new analgesics, they reported in the Oct. 14, 2019, edition of Proceedings of the National Academy of Sciences (PNAS).
Read More

BioWorld MedTech's Oncology Extra

Oct. 23, 2019
By Mark McCarty and Anette Breindl
No Comments
Keeping you up to date on recent developments in oncology.
Read More

UCSF, Berkeley researchers develop brain bleed algorithm that bests expert radiologists

Oct. 23, 2019
By Stacy Lawrence
No Comments
Radiologists review thousands of images a day. The hope is that artificial intelligence (AI) applications will become useful soon to verify diagnoses, prioritize queued images and even to offer a level of detection and measurement that aren't feasible for humans. One of the latest efforts on this front is by researchers at the University of California at San Francisco (UCSF) and the University of California at Berkeley.
Read More
The BioWorld Biome

New method moves genome editing toward 'prime' time

Oct. 23, 2019
By Anette Breindl
No Comments
A team at the Broad Institute of Harvard and MIT has developed a genome editing method that could, in principle, correct 90% of the roughly 75,000 currently known genomic changes that are associated with genetic diseases.
Read More

With new method, genome editing moves toward 'prime' time

Oct. 22, 2019
By Anette Breindl
No Comments
A team at the Broad Institute of Harvard and MIT has developed a genome editing method that could, in principle, correct 90% of the roughly 75,000 currently known genomic changes that are associated with genetic diseases.
Read More

BioWorld MedTech's Cardiology Extra

Oct. 22, 2019
By Liz Hollis
No Comments
Keeping you up to date on recent developments in cardiology.
Read More

Bench Press for Oct. 21, 2019

Oct. 21, 2019
By Anette Breindl
No Comments
BioWorld looks at translational medicine.
Read More
Previous 1 2 … 125 126 127 128 129 130 131 132 133 134 135 Next

Popular Stories

  • Free access to BioWorld coronavirus articles

    BioWorld

    The articles in this collection are from BioWorld’s ongoing coverage of the COVID-19 coronavirus outbreak. Note that we have added three critical tables which are...

  • Novavax-COVID-19-vaccine-vial

    Novavax vaccine shows its chops

    BioWorld
    Given that Novavax Inc.’s COVID-19 vaccine will be a latecomer to the U.S. scene if it gets FDA authorization, it’s been cast in a supporting role to the lead...
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech's briefs for July 1.
  • Blood sample, DNA

    Biomarin outlines pricing strategy for costly hemophilia A gene therapy after backing from European regulators

    BioWorld
    The first gene therapy to treat severe hemophilia A was among the drugs recommended for European approval by regulators from the EMA’s CHMP at its monthly...
  • Cells and DNA helix

    Bluebird’s eli-cel gene therapy for CALD snatches adcom victory from jaws of defeat

    BioWorld
    The Cellular, Tissue and Gene Therapies Advisory Committee scrutinized Bluebird Bio Inc.’s gene therapy elivaldogene autotemcel (eli-cel) for early active...
black cortellis ad

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Subscribe
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Archives
    • Today's news
    • Search BioWorld Science
    • About
  • More
    • About
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
Follow Us

Copyright ©2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing